{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:55:03Z","timestamp":1794891303639,"version":"4.9.1"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:p>Inflammatory myofibroblastic tumor (IMT) of the uterus is a rare mesenchymal tumor with largely benign behavior; however, a small subset demonstrate aggressive behavior. While clinicopathologic features have been previously associated with aggressive behavior, these reports are based on small series, and these features are imperfect predictors of clinical behavior. IMTs are most commonly driven by <jats:italic toggle=\"yes\">ALK<\/jats:italic> fusions, with additional pathogenic molecular alterations being reported only in rare examples of extrauterine IMTs. In this study, a series of 11 uterine IMTs, 5 of which demonstrated aggressive behavior, were evaluated for clinicopathologic variables and additionally subjected to capture-based next-generation sequencing with or without whole-transcriptome RNA sequencing. In the 6 IMTs without aggressive behavior, <jats:italic toggle=\"yes\">ALK<\/jats:italic> fusions were the sole pathogenic alteration. In contrast, all 5 aggressive IMTs harbored pathogenic molecular alterations and numerous copy number changes in addition to <jats:italic toggle=\"yes\">ALK<\/jats:italic> fusions, with the majority of the additional alterations present in the primary tumors. We combined our series with cases previously reported in the literature and performed statistical analyses to propose a novel clinicopathologic risk stratification score assigning 1 point each for: age above 45 years, size\u22655\u00a0cm,\u22654 mitotic figures per 10 high-power field, and infiltrative borders. No tumors with 0 points had an aggressive outcome, while 21% of tumors with 1 to 2 points and all tumors with \u22653 points had aggressive outcomes. We propose a 2-step classification model that first uses the clinicopathologic risk stratification score to identify low-risk and high-risk tumors, and recommend molecular testing to further classify intermediate-risk tumors.<\/jats:p>","DOI":"10.1097\/pas.0000000000001987","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T04:00:22Z","timestamp":1667880022000},"page":"157-171","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":37,"title":["Uterine Inflammatory Myofibroblastic Tumors"],"prefix":"10.1097","volume":"47","author":[{"given":"Nicholas R.","family":"Ladwig","sequence":"first","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Bean","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melike","family":"Pekmezci","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Boscardin","sequence":"additional","affiliation":[{"name":"Medicine and Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy M.","family":"Joseph","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Therrien","sequence":"additional","affiliation":[{"name":"Department of Pathology, Logan Health, Kalispell, MT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur R.","family":"Sangoi","sequence":"additional","affiliation":[{"name":"Department of Pathology, El Camino Hospital, Mountain View, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Piening","sequence":"additional","affiliation":[{"name":"Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesh","family":"Rajamanickam","sequence":"additional","affiliation":[{"name":"Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Galvin","sequence":"additional","affiliation":[{"name":"Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brady","family":"Bernard","sequence":"additional","affiliation":[{"name":"Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Zaloudek","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Rabban","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuna","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2175-0671","authenticated-orcid":false,"given":"Sarah E.","family":"Umetsu","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/PAS.0000000000000909","article-title":"Inflammatory myofibroblastic tumors of the female genital tract are under-recognized: a low threshold for ALK immunohistochemistry is required","volume":"41","author":"Pickett","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/PAS.0000000000001083","article-title":"ALK-rearranged tumors are highly enriched in the STUMP subcategory of uterine tumors","volume":"43","author":"Devereaux","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAS.0000000000000593","article-title":"Myxoid leiomyosarcoma of the uterus: a clinicopathologic analysis of 30 cases and review of the literature with reappraisal of its distinction from other uterine myxoid mesenchymal neoplasms","volume":"40","author":"Parra-Herran","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"e8974","DOI":"10.1097\/MD.0000000000008974","article-title":"Uterine inflammatory myofibroblastic tumor: more common than expected: case report and review","volume":"96","author":"Mandato","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13045-015-0160-2","article-title":"STUMP un\u201cstumped\u201d: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion","volume":"8","author":"Subbiah","year":"2015","journal-title":"J Hematol Oncol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/PAS.0000000000000330","article-title":"Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course","volume":"39","author":"Parra-Herran","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/modpathol.2017.69","article-title":"Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum","volume":"30","author":"Bennett","year":"2017","journal-title":"Mod Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/PAS.0000000000000801","article-title":"Uterine inflammatory myofibroblastic tumors frequently harbor ALK fusions with IGFBP5 and THBS1","volume":"41","author":"Haimes","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/PAS.0000000000001481","article-title":"Pregnancy-associated inflammatory myofibroblastic tumors of the uterus are clinically distinct and highly enriched for TIMP3-ALK and THBS1-ALK fusions","volume":"44","author":"Devereaux","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.humpath.2019.12.006","article-title":"Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion","volume":"97","author":"Cheek","year":"2020","journal-title":"Hum Pathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.humpath.2020.09.005","article-title":"Inflammatory myofibroblastic tumors associated with the placenta: a series of 9 cases","volume":"106","author":"Makhdoum","year":"2020","journal-title":"Hum Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.humpath.2020.03.014","article-title":"Uterine inflammatory myofibroblastic tumor involving the decidua of the extraplacental membranes: report of a case with a TIMP3-ROS1 gene fusion","volume":"100","author":"Schoolmeester","year":"2020","journal-title":"Hum Pathol"},{"key":"R13-20250608","first-page":"244","article-title":"Inflammatory myofibroblastic tumor of salpinx: a very rare case treated with a less aggressive method","volume":"7","author":"Homaei-Shandiz","year":"2014","journal-title":"Iran J Cancer Prev"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.gynor.2013.07.007","article-title":"Extrauterine inflammatory myofibroblastic tumor: a case report","volume":"6","author":"Kushnir","year":"2013","journal-title":"Gynecol Oncol Case Rep"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"e12991","DOI":"10.5812\/iranjradiol.12991","article-title":"Follow-up imaging of inflammatory myofibroblastic tumor of the uterus and its spontaneous regression","volume":"13","author":"Markovic Vasiljkovic","year":"2016","journal-title":"Iran J Radiol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejogrb.2011.02.016","article-title":"Hysteroscopic excision of inflammatory myofibroblastic tumor of the uterus: a case report and brief review","volume":"157","author":"Olgan","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jpag.2007.05.006","article-title":"Ovarian inflammatory myofibroblastic tumor in children","volume":"20","author":"Sahnoun","year":"2007","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/01.pas.0000172189.02424.91","article-title":"Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors","volume":"29","author":"Rabban","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"623","DOI":"10.5858\/arpa.2011-0341-OA","article-title":"ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract","volume":"136","author":"Fuehrer","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1440-1827.2006.02018.x","article-title":"Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change","volume":"56","author":"Shintaku","year":"2006","journal-title":"Pathol Int"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000478-199508000-00001","article-title":"Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases","volume":"19","author":"Coffin","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejogrb.2011.01.002","article-title":"Inflammatory pseudotumor of uterus: an unusual pelvic mass","volume":"156","author":"Gupta","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1200\/JCO.2013.48.8304","article-title":"Uterine inflammatory myofibroblastic tumor in a 10-year-old girl presenting as polypoid mass","volume":"33","author":"Fraggetta","year":"2015","journal-title":"J Clin Oncol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/PGP.0000000000000175","article-title":"Inflammatory myofibroblastic tumor of the placenta: a report of a novel lesion in 2 patients","volume":"34","author":"Banet","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/PAS.0000000000000404","article-title":"Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement","volume":"39","author":"Antonescu","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/2159-8290.CD-14-0377","article-title":"Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions","volume":"4","author":"Lovly","year":"2014","journal-title":"Cancer Discov"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1177\/0300060518780873","article-title":"Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report","volume":"46","author":"Takahashi","year":"2018","journal-title":"J Int Med Res"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/01.pas.0000213393.57322.c7","article-title":"Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases","volume":"31","author":"Coffin","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/PAS.0000000000001756","article-title":"Uterine inflammatory myofibroblastic neoplasms with aggressive behavior, including an epithelioid inflammatory myofibroblastic sarcoma: a clinicopathologic study of 9 cases","volume":"46","author":"Collins","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"e19577","DOI":"10.1097\/MD.0000000000019577","article-title":"Over expression of CDK4 and MDM2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor: a case report","volume":"99","author":"Hou","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/PAS.0b013e318200cfd5","article-title":"Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK","volume":"35","author":"Marino-Enriquez","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.humpath.2008.04.016","article-title":"An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features","volume":"39","author":"Chen","year":"2008","journal-title":"Hum Pathol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cancergencyto.2007.04.004","article-title":"RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors","volume":"176","author":"Patel","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/PGP.0000000000000431","article-title":"Epithelioid inflammatory myofibroblastic sarcoma of the ovary with RANB2-ALK fusion: report of a case","volume":"37","author":"Fang","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/gcc.10177","article-title":"Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor","volume":"37","author":"Ma","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/PAS.0000000000001525","article-title":"Inflammatory myofibroblastic tumor of the uterus: an immunohistochemical study of 23 cases","volume":"44","author":"Bennett","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/PAS.0000000000001044","article-title":"Inflammatory myofibroblastic tumor associated with the placenta: short tandem repeat genotyping confirms uterine site of origin","volume":"42","author":"Ladwig","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/PGP.0000000000000704","article-title":"ALK immunohistochemistry and molecular analysis in uterine inflammatory myofibroblastic tumor: proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting","volume":"40","author":"Parra-Herran","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/PGP.0000000000000725","article-title":"The many uses of p53 immunohistochemistry in gynecological pathology: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual 9 Meeting","volume":"40","author":"Kobel","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"R44-20250608","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/gepi.21650","article-title":"Haplotype-based methods for detecting uncommon causal variants with common SNPs","volume":"36","author":"Lin","year":"2012","journal-title":"Genet Epidemiol"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","article-title":"DELLY: structural variant discovery by integrated paired-end and split-read analysis","volume":"28","author":"Rausch","year":"2012","journal-title":"Bioinformatics"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"R48-20250608","doi-asserted-by":"crossref","first-page":"11 10 11","DOI":"10.1002\/0471250953.bi1110s43","article-title":"From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline","volume":"43","author":"Van der Auwera","year":"2013","journal-title":"Curr Protoc Bioinformatics"},{"key":"R49-20250608","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/nprot.2015.105","article-title":"Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR","volume":"10","author":"Yang","year":"2015","journal-title":"Nat Protoc"},{"key":"R51-20250608","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","article-title":"Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads","volume":"25","author":"Ye","year":"2009","journal-title":"Bioinformatics"},{"key":"R52-20250608","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing","volume":"467","author":"Genomes Project","year":"2010","journal-title":"Nature"},{"key":"R53-20250608","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/his.14292","article-title":"p53 immunohistochemical analysis of fusion-positive uterine sarcomas","volume":"78","author":"Mohammad","year":"2021","journal-title":"Histopathology"},{"key":"R54-20250608","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/his.13176","article-title":"Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour","volume":"70","author":"Schaefer","year":"2017","journal-title":"Histopathology"},{"key":"R55-20250608","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41467-017-02602-0","article-title":"Integrative genomic and transcriptomic analysis of leiomyosarcoma","volume":"9","author":"Chudasama","year":"2018","journal-title":"Nat Commun"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001987","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:01:08Z","timestamp":1749416468000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001987"}},"subtitle":["Proposed Risk Stratification Model Using Integrated Clinicopathologic and Molecular Analysis"],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001987","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,7]]}}}